Por favor, use este identificador para citar o enlazar este ítem:
http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/4989| Diabetes is a risk factor for the progression and prognosis of COVID-19 | |
| Guo Weina. Li Mingyue. Dong Yalan. Zhou Haifeng. Zhang Zili. Tian Chunxia. Qin Renjie. Wang Haijun. Shen Yin. Du Keye. Zhao Lei. Fan Heng. Luo Shanshan. Hu Desheng. | |
| Acceso Abierto | |
| Atribución-NoComercial-SinDerivadas | |
| 10.1002/dmrr.3319 | |
| BACKGOUND:To figure out whether diabetes is a risk factor influencing the progression and prognosis of 2019 novel coronavirus disease (COVID-19). METHODS:A total of 174 consecutive patients confirmed with COVID-19 were studied. Demographic data, medical history, symptoms and signs, laboratory findings, chest computed tomography (CT) as well the treatment measures were collected and analysed. RESULTS:We found that COVID-19 patients without other comorbidities but with diabetes (n = 24) were at higher risk of severe pneumonia, release of tissue injury-related enzymes, excessive uncontrolled inflammation responses and hypercoagulable state associated with dysregulation of glucose metabolism. Furthermore, serum levels of inflammation-related biomarkers such as IL-6, C-reactive protein, serum ferritin and coagulation index, D-dimer, were significantly higher (P | |
| Diabetes/Metabolism Research and Reviews | |
| 2020 | |
| Artículo | |
| https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/dmrr.3319 | |
| Inglés | |
| VIRUS RESPIRATORIOS | |
| Aparece en las colecciones: | Artículos científicos |
Cargar archivos:
| Fichero | Tamaño | Formato | |
|---|---|---|---|
| 1108002.pdf | 1.32 MB | Adobe PDF | Visualizar/Abrir |